|
|
|
Insider
Information: |
Smith Ian F |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
267,823 |
|
Indirect Shares
|
5,306 |
|
|
Direct
Value |
$22,658,153 |
|
|
Indirect Value
|
$2,507,138 |
|
|
Total
Shares |
273,129 |
|
|
Total
Value |
$25,165,291 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2012-10-08 |
4 |
AS |
$60.00 |
$2,687,220 |
D/D |
(44,787) |
24,168 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2012-10-08 |
4 |
OE |
$10.41 |
$765,303 |
D/D |
43,949 |
68,955 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2012-10-11 |
4 |
OE |
$18.93 |
$341,943 |
D/D |
14,043 |
38,211 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2012-10-11 |
4 |
AS |
$60.00 |
$842,580 |
D/D |
(14,043) |
24,168 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2012-11-16 |
4 |
AS |
$41.26 |
$249,293 |
D/D |
(6,042) |
18,126 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2013-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
30,210 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2013-04-19 |
4 |
AS |
$81.50 |
$60,963,612 |
D/D |
(745,685) |
24,168 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2013-04-19 |
4 |
OE |
$28.84 |
$25,545,249 |
D/D |
739,643 |
769,853 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2013-05-15 |
4 |
AS |
$79.51 |
$48,521 |
D/D |
(609) |
24,168 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2014-02-05 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
44,868 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2014-09-30 |
4 |
OE |
$33.28 |
$4,528,419 |
D/D |
107,624 |
152,894 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2014-09-30 |
4 |
AS |
$111.31 |
$12,172,023 |
D/D |
(108,026) |
44,868 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2014-10-30 |
4 |
A |
$0.01 |
$750 |
D/D |
75,000 |
119,868 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2014-12-12 |
4 |
AS |
$119.82 |
$725,738 |
D/D |
(6,042) |
113,826 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2015-02-03 |
4 |
A |
$0.01 |
$207 |
D/D |
20,700 |
134,526 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2015-02-18 |
4 |
AS |
$112.66 |
$1,168,428 |
D/D |
(10,350) |
124,176 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2015-03-23 |
4 |
AS |
$122.44 |
$759,277 |
D/D |
(6,042) |
118,134 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2015-05-15 |
4 |
AS |
$123.85 |
$47,484 |
D/D |
(378) |
118,134 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2015-10-30 |
4 |
AS |
$124.95 |
$1,302,727 |
D/D |
(10,350) |
107,784 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2016-01-04 |
4 |
OE |
$17.85 |
$242,093 |
D/D |
13,231 |
13,231 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2016-01-04 |
4 |
AS |
$41.85 |
$553,706 |
D/D |
(13,231) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2016-02-02 |
4 |
A |
$0.01 |
$173 |
D/D |
17,299 |
125,083 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2016-02-03 |
4 |
AS |
$89.90 |
$1,097,691 |
D/D |
(12,084) |
112,999 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
|
2016-05-16 |
4 |
AS |
$82.06 |
$16,576 |
D/D |
(202) |
112,999 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
|
2017-02-03 |
4 |
A |
$0.00 |
$58 |
D/D |
20,923 |
133,922 |
0 |
- |
|
128 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|